South Korea's YNCC has restored run rates at its 1.9 mln tpa to 100% at its naphtha cracking complex on Monday amid improved petrochemical profits, as per Reuters. Improving demand from China has triggered the improvement. In H2 May, YNCC had reduced utilization rates to 90% in the face of squeezed margins. China is restocking over the last two-three weeks.
Previous News
Next News
-
Despite restart of naphtha unit, CPC to skip spot naphtha purchase in Q3
-
Oil prices drop in Asia on opening of alternative crude pipelines bypassing Strait of Hormuz
-
Taiwan's Kuokuang to set up petrochemical plant in Malaysia
-
MRPL sells naphtha at sharply higher premiums amid strong market fundamentals
-
Course of Plastics Manufacturing Process -Recent Trends ,Trouble shooting & Quality Control
-
Mid-Eastern producers cut July PE prices in Egypt, raise Aug outlook
-
BASF named world’s most transparent chemical company globally
-
Tver oil refining complex mulls petrochemical unit in Zhytomyr region
-
Ningbo Mitsubishi to continue operating at 100%, the 600,000 tpa PTA plant despite negative margins
-
Naphtha in Asia hovers around 6 week highs
-
Samvardhana Motherson International Limited India’s Global Automotive Plastics & Systems Powerhouse
-
Varroc Engineering Limited: From Polymer Components to a Global Automotive Systems Leader
-
Hitech Corporation Ltd - Prominent Manufacturer of Rigid Plastic Packaging Products, Serving Paints, Agrochemicals, Lubricants, FMCG, and Food Industries.
-
Mold-Tek Packaging Ltd – Leader in IML-Based Rigid Plastic Packaging Solutions
-
Bhansali Engineering Polymers Ltd. Expands Engineering Plastics Capacity in India
-
Styrenix Industries: Leading ABS & SAN Resin Producer in India
-
Chemplast Sanmar Ltd India’s Specialist PVC Resin & Paste PVC Manufacturer
-
BASF To Showcase Innovative and Sustainable Solutions at PlastIndia 2026
-
Essel Propack (EPL Limited): Engineering Multilayer Laminated Tube Packaging at Global Scale
-
Shaily Engineering Plastics: India’s Precision Plastics Partner to Global Med-Tech and Pharma Innovators
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}